OpenFilings

ORAMED PHARMACEUTICALS INC.

Form10-K

Report Period2022-12-31

Date Filed2023-03-06

Time Filed17:01:43

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

ANNUAL REPORT
DESCRIPTION OF SECURITIES
CONSULTING AGREEMENT BY AND BETWEEN ORAMED PHARMACEUTICALS INC. AND SHNIDA LTD.,
EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED LTD. AND NADAV KIDRON, ENTERED INTO A
SECOND AMENDMENT, DATED OCTOBER 25, 2022, TO EMPLOYMENT AGREEMENT, BY AND BETWEE
REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS
FORM OF RESTRICTED STOCK UNIT NOTICE AND RESTRICTED STOCK UNIT AGREEMENT
ORAVAX MEDICAL, INC. 2021 LONG-TERM INCENTIVE PLAN
ORAVAX STOCK OPTION AGREEMENT
CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CERTIFICATION
CERTIFICATION
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar